Atrial Fibrillation

New Atrial Fibrillation Treatment Approved for use in Canadian Pharmacies

New Atrial Fibrillation Treatment Approved for use in Canadian Pharmacies

A new treatment for atrial fibrillation – a common heart condition that is also known as an irregular heartbeat or arrhythmia, has been approved for consumer use in both Canada and the United States. This new medication,  Pradaxa, is intended to prevent the formation of blood clots, which can lead to stroke. The approval of Pradaxa marks an extremely large step for the treatment of atrial fibrillation, as the last treatment, called warfarin, was introduced to North American pharmacies more than fifty years ago for the prevention of stroke as a result of this condition.

In comparison to warfarin, Pradaxa (which is also known as dabigatran) has been shown to reduce the risk of stroke by thirty-four percent, in addition to reducing the bleeding complications that are often associated with the use of warfarin. Pradaxa also does not require the same amount of monitoring that is required with the use of warfarin. Patients taking warfarin require frequent monitoring in order to ensure that their blood is within a safe consistency to allow the drug to be effective, while at the same time preventing bleeds. Pradaxa is specially formulated to inhibit the production of blood clots safely, as it works on a specific protein involved in the blood clotting process soon after ingestion.

Atrial fibrillation is a serious heart condition that affects over two million North Americans, as it drastically increases the risk of stroke. It is estimated that one third of all strokes in patients over the age of sixty are caused by atrial fibrillation. Although there are many available treatments, including anticoagulants and anti-arrhythmics for atrial fibrillation, healthcare professionals have not yet identified the cause of this condition.

Pradaxa is now available to consumers in the United States and Canada for the treatment of atrial fibrillation as a preventative option for stroke and blood clotting. For patients concerned with the expensive pricing attributed to the recent approval of Pradaxa; it can be obtained at your local Canadian pharmacy for the most inexpensive price. offers low-cost long-term prescription medications to both local and international clients. Online Pharmacies Canada is ranked as one of the best (five-star) online pharmacies by and additionally is a certified member of the Canadian International Pharmacy Association.